Abstract
RiboBio, a Chinese specialist in nucleic acid research, and GE Healthcare Life Sciences have formed a venture to build what they say will be Asia’s largest oligonucleotide manufacturing facility. GE will provide instrumentation including a laser-based cell imaging system and an automated oligo synthesizer. RiboBio built China’s first oligo facility in 2013. Nitto Denko Avecia claims to operate the world’s largest oligo plant in Milford, Mass.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
